Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chambio
Taiwan
- Ownership
- Private
- Development stage
- Other
01
Overview
Chambio commercializes proprietary nutraceutical formulations and bioactive ingredients supported by clinical studies and patents, with marketed products addressing gut health, skin health, sleep, immune function, and more, and recognized by multiple innovation and safety awards[1].
- Therapeutic areas
- OphthalmologyEndocrinologyRheumatologyGastroenterologyNeurologyPulmonologyOtherDermatologyPsychiatry
- Modalities
- Small moleculeProbioticPostbioticPlant extractPeptides
- Industry
- Food & Nutrition
02
Partnerships
International suppliers of bioactive ingredients (Europe, USA, Japan, South Korea)Multinational pharmaceutical, nutraceutical, and cosmetic companies as clients
Beyond the preview
Go deeper on Chambio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chambio.